SLC2A1 and type 2 diabetes mellitus: Unlike GLUT1 and GLUT4, which expression is down-regulated in diabetic hearts, SGLT1 expression is increased in individuals with end-stage cardiomyopathy secondary to T2DM and in obese mice [27].